Figure 8.
Putative effects of lysophosphatidylethanolamine (lysoPE) on hepatic lipid metabolism. The present study demonstrated that lysoPE 18:2 supplementation induced hepatic lipid accumulation and caused lipid profile alteration, possibly related to the suppression of lipolysis, fatty acid synthesis and fatty acid uptake.